EECP (Enhanced external counter-pulsation)

EECP (Enhanced external counter-pulsation)

Dr. Mohammad Afzal Siddiqui

Review By Dr. Mohammad Afzal Siddiqui
Award-winning CEO of Marlin Medical Assistance Pvt. Ltd

Nov 3, 2022

Stable Angina is managed primarily through lifestyle advice, medication therapy, and coronary revascularization procedures. Some patients with refractory angina exhibit symptoms that are not optimally controlled with the optimal medication and revascularization options available. Enhanced external counter-pulsation (EECP) is a technique that can be used to improve symptoms in chronic stable angina.

However, the role of EECP has also been investigated following positive outcomes in patients with both angina and heart failure in multi-center studies.

EECP is accepted by the United States Food and Drug Administration (FDA) for the treatment of refractory angina (Class IIb). About 200 hospitals all over India have equipped themselves with this technology.

USES:

EECP uses three groups of pneumatic cuffs that orderly contract during diastole, enhancing aortic diastolic pressure, improving coronary blood movement, etc.

Improves anginal symptoms and exercise tolerance, and reduces nitro-glycerine use in patients with chronic, stable angina. EECP is also found to be safe and helpful in patients with symptomatic steady congestive heart failure. It has been predicted that the cardiac benefits of EECP are transferred through vascular endothelial growth factor, and nitric oxide creates vasodilatation and angiogenesis. In June 2002, the FDA also validated EECP therapy for heart-stuck patients. EECP is cost-effective if the detected quality of life benefit is deduced to continue all over the patient’s lifetime.

However, there remain uncertainties around the long-term effects of the intervention.

Get in Touch with Medical Experts

You must agree before submitting.
Dr. Mohammad Afzal Siddiqui

Written by

Dr. Mohammad Afzal Siddiqui

Award-winning CEO of Marlin Medical Assistance Pvt. Ltd

Dr. Mohammad Afzal Siddiqui is an award-winning CEO of Marlin Medical Assistance Pvt. Ltd., a professionally managed medical tourism holding company and the active Director of Alshifa Healthcare Services Pvt. Ltd., a full-service medical tourism aggregation agency servicing JCI and NABH/ NABL accredited Hospitals across the country’s 5 locations.

In addition to Marlin, Alshifa also includes Media Group, which houses Arabic Medical Tourism e-Magazine healthandtour.com. The E-magazine “مجلة الصحة والسياحة” provides a wide scope of medical tourism information to healthcare travellers to find a safe, effective and cost-saving solution for their medical and healthcare needs. In addition to running E-Magazine, Dr. Mohammad Afzal also serves as Delhi-state coordinator in Foundation of Healthcare and Wellness Promotion focused on bringing India’s Healthcare closer to the world and smoothen world’s access to Indian Healthcare.

Our world-class medical experts would be happy to assist you.
or Call

Made in NextJs 13, by Digital Transformation Agency - Ima-appweb.com